Amylyx Pharmaceuticals, Inc.
2022 Q1 - 2025 Q4 (12 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 955 | 0.0% | 79,090 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 59 | 0.0% | 4,331 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 28 | 0.0% | 4,328 | 6/30/2025 |
| 2024 Q1 | 5/16/2024 | 127 | 0.0% | 44,561 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 653 | 0.0% | 44,388 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 694 | 0.0% | 37,919 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 934 | 0.0% | 43,307 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 550 | 0.0% | 18,762 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 744 | 0.0% | 20,131 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 392 | 0.0% | 13,923 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 94 | 0.0% | 4,905 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 53 | 0.0% | 4,086 | 3/31/2022 |